Blood lipid and ceramide profiles in atrial fibrillation
Official title: Association of Peripheral Blood Lipidomic and Ceramide Profiles With Atrial Fibrillation: A Prospective Multi-Cohort Observational Study
Run by First Affiliated Hospital Xi'an Jiaotong University · NCT07757282 · Data updated 2026-11-12
This study tests whether blood lipid and ceramide patterns differ between people with atrial fibrillation and those with other heart diseases.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | First Affiliated Hospital Xi'an Jiaotong University Academic / other |
| Locations | 1 site (Xi'an, Shaanxi) |
| Status | Recruiting |
| Started | June 15, 2017 |
| Main results expected | January 2027 |
| Study ends | February 2027 |
| Registry record updated | August 11, 2026 |
| Trial ID | NCT07757282 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years and older with atrial fibrillation or with cardiovascular disease but no AF, who can provide informed consent and have suitable blood samples.
✕Probably not a fit
Participants with AF or cardiovascular disease who have unsuitable blood samples or do not show any lipidomic or ceramide differences related to AF may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, multi-cohort observational study comparing peripheral blood lipidomic features and ceramide profiles in adults with atrial fibrillation to controls with cardiovascular disease but no AF. One cohort will undergo untargeted lipidomic profiling and another will have targeted ceramide assays. Participants are classified by Holter monitoring and clinical data, and samples are analyzed to explore associations with atrial fibrillation. The study is conducted at the First Affiliated Hospital of Xi’an Jiaotong University, without an interventional treatment. Findings could help clarify whether lipid and ceramide patterns are linked to AF pathophysiology.
Why it matters
Potential benefit: If successful, the results may improve understanding of AF biology and identify potential biomarkers for risk or diagnosis.
How similar studies have gone: Prior research suggests lipid and sphingolipid metabolism may be linked to AF, but translationally useful biomarkers remain to be validated; this study adds targeted comparisons.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years or older. * Participants who are able to provide informed consent. * Participants diagnosed with atrial fibrillation based on Holter monitoring, or control participants with other cardiovascular diseases and no documented atrial fibrillation. * Participants with available peripheral blood samples for untargeted lipidomic profiling or targeted ceramide analysis. Exclusion Criteria: * Inability or unwillingness to provide informed consent. * Missing key clinical information. * Missing or poor-quality peripheral blood samples unsuitable for lipidomic or targeted ceramide analysis. * Participants considered unsuitable for this study by the investigators.
Where it's running
-
First Affiliated Hospital of Xian JiaotongUniversity
Xi'an, Shaanxi, China Recruiting
Study contacts
- Study coordinator: Weiyan Zhang
- Email: zwhy19324@gmail.com
- Phone: 0086-13571200428
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation
This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.
-
Pulsed Field Ablation vs Cryoablation for Atrial Fibrillation Under Deep Sedation
This trial tests whether pulsed field ablation (PFA) done under deep sedation works as well as cryoballoon ablation for treating atrial fibrillation, aiming to avoid general anesthesia.
-
Bachmann’s Bundle Pacing vs Right Atrial Appendage Pacing for AF
This study tests two common atrial pacing methods to see which one is safer over 12 months for people getting a new pacemaker, ICD, or CRT device.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Pace-and-ablate strategy in atrial fibrillation: who benefits and long-term outcomes
This study looks at adults with atrial fibrillation who underwent AV node ablation with permanent pacing to see who develops pacing-induced problems and how they do long-term.
-
AI-based cardiac analysis using 12-lead and 1-lead ECG
A clinician-facing pilot test to see if SmartECG-EF helps evaluate heart function using both 12-lead and single-lead ECGs in adults with heart conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.